Literature DB >> 19169853

Insights into the role and function of L2, the minor capsid protein of papillomaviruses.

Ramon Pereira1, Inga I Hitzeroth, Edward P Rybicki.   

Abstract

Human papillomaviruses (HPV) are responsible for the most common human sexually transmitted viral infections, and high-risk types are responsible for causing cervical and other cancers. The minor capsid protein L2 of HPV plays important roles in virus entry into cells, localisation of viral components to the nucleus, in DNA binding, capsid formation and stability. It also elicits antibodies that are more cross-reactive between HPV types than does the major capsid protein L1, making it an attractive potential target for new-generation, more broadly protective subunit vaccines against HPV infections. However, its low abundance in natural capsids--12-72 molecules per 360 copies of L1--limits its immunogenicity. This review will explore the biological roles of the protein, and prospects for its use in new vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169853     DOI: 10.1007/s00705-009-0310-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Modification of human papillomavirus minor capsid protein L2 by sumoylation.

Authors:  Martina Bergant Marusic; Nina Mencin; Mia Licen; Lawrence Banks; Helena Sterlinko Grm
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  HPV L1 capsid protein detection and progression of anal squamous neoplasia.

Authors:  Jonathan Hernandez; Abul Elahi; Erin Siegel; Domenico Coppola; Bridgett Riggs; David Shibata
Journal:  Am J Clin Pathol       Date:  2011-03       Impact factor: 2.493

Review 3.  HPV, hypoxia and radiation response in head and neck cancer.

Authors:  Eva-Leonne Göttgens; Christian Ostheimer; Paul N Span; Jan Bussink; Ester M Hammond
Journal:  Br J Radiol       Date:  2018-03-14       Impact factor: 3.039

4.  Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17.

Authors:  Martina Bergant Marušič; Michelle A Ozbun; Samuel K Campos; Michael P Myers; Lawrence Banks
Journal:  Traffic       Date:  2012-01-08       Impact factor: 6.215

5.  In vivo mechanisms of vaccine-induced protection against HPV infection.

Authors:  Patricia M Day; Rhonda C Kines; Cynthia D Thompson; Subhashini Jagu; Richard B Roden; Douglas R Lowy; John T Schiller
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

6.  Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus.

Authors:  Alex Lipovsky; Andreea Popa; Genaro Pimienta; Michael Wyler; Ashima Bhan; Leena Kuruvilla; Marie-Aude Guie; Adrian C Poffenberger; Christian D S Nelson; Walter J Atwood; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

7.  SNX17 facilitates infection with diverse papillomavirus types.

Authors:  Martina Bergant; Lawrence Banks
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

8.  The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network.

Authors:  Mandy Muller; Caroline Demeret
Journal:  Open Virol J       Date:  2012-12-28

9.  The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.

Authors:  Andrew W Woodham; Diane M Da Silva; Joseph G Skeate; Adam B Raff; Mark R Ambroso; Heike E Brand; J Mario Isas; Ralf Langen; W Martin Kast
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

10.  Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China.

Authors:  Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.